{"disease":{"id":"leber-s-hereditary-optic-neuropathy","name":"leber s hereditary optic neuropathy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04912843","title":"Gene Therapy Clinical Trial for the Treatment Of Leber's HereDitary Optic Neuropathy","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":102,"lead_sponsor_name":"Wuhan Neurophth Biotechnology Limited Company","has_results":false},{"nct_id":"NCT04909398","title":"Pupil Dynamics and Color Vision for the Detection of Eye Diseases","phase":"NA","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts","has_results":false},{"nct_id":"NCT02161380","title":"Safety Study of an Adeno-associated Virus Vector for Gene Therapy of Leber's Hereditary Optic Neuropathy","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":28,"lead_sponsor_name":"Byron Lam","has_results":true},{"nct_id":"NCT05555784","title":"Evaluation of Impact of Disease and Visual Disability on Quality of Life and Loss of Independence of Patients Living in France With Leber's Hereditary Optic Neuropathy (LHON) Through Qualitative and Quantitative Data Collection","phase":"","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Argo Sante","has_results":false},{"nct_id":"NCT04381091","title":"Expanded Access Program for Idebenone in Patients With Leber's Hereditary Optic Neuropathy Who Completed the LEROS Study","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Santhera Pharmaceuticals","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}